Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dandan Hu

Showing results (201-210 of 333) with videos related to

Pageof 34
Sort By:
Annals of Botany|June 5, 2019
Responses of community structure and diversity to nitrogen deposition and rainfall addition in contrasting steppes are ecosystem-dependent and dwarfed by year-to-year community dynamicsXuejun Yang, Zhenying Huang, Ming Dong, et al.
BMC Cancer|September 19, 2024
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort studyLiyang Sun, Zhiwen Hu, Wa Xie, et al.
Brain Communications|October 10, 2024
CD8 positive T-cells decrease neurogenesis and induce anxiety-like behaviour following hepatitis B vaccinationTuo Zhou, Yuxuan Gao, Zhiling Wang, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|February 23, 2022
Cascade i-motifs-dependent reversibleelectrochemical impedance strategy-oriented pH and terminal deoxynucleotidyl transferase biosensingYudi Zheng, Dandan Hu, Di Wu, et al.
Frontiers in Pharmacology|March 3, 2022
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune ScoreYongjiang Li, Yangxun Pan, Ximeng Lin, et al.
Oncotarget|January 5, 2018
Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteriaWei Xu, Rui Guo, Gang Xu, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2022
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world studyJinbin Chen, Peiyao Xiong, Man Nie, et al.
Journal of Hepatocellular Carcinoma|December 9, 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 ImmunotherapyXuqi Sun, Dandan Hu, Zhoutian Yang, et al.
Journal of Hepatocellular Carcinoma|October 26, 2023
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaTeng Long, Zhoutian Yang, Huilan Zeng, et al.
Plant Biotechnology Journal|November 24, 2018
Reconstituting the genome of a young allopolyploid crop, Brassica napus, with its related speciesDandan Hu, Wenshan Zhang, Yikai Zhang, et al.
Pageof 34

Showing results (201-210 of 333) with videos related to

Sort By:
Pageof 34
Annals of Botany|June 5, 2019
Responses of community structure and diversity to nitrogen deposition and rainfall addition in contrasting steppes are ecosystem-dependent and dwarfed by year-to-year community dynamicsXuejun Yang, Zhenying Huang, Ming Dong, et al.
BMC Cancer|September 19, 2024
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort studyLiyang Sun, Zhiwen Hu, Wa Xie, et al.
Brain Communications|October 10, 2024
CD8 positive T-cells decrease neurogenesis and induce anxiety-like behaviour following hepatitis B vaccinationTuo Zhou, Yuxuan Gao, Zhiling Wang, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|February 23, 2022
Cascade i-motifs-dependent reversibleelectrochemical impedance strategy-oriented pH and terminal deoxynucleotidyl transferase biosensingYudi Zheng, Dandan Hu, Di Wu, et al.
Frontiers in Pharmacology|March 3, 2022
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune ScoreYongjiang Li, Yangxun Pan, Ximeng Lin, et al.
Oncotarget|January 5, 2018
Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteriaWei Xu, Rui Guo, Gang Xu, et al.
Journal of Cancer Research and Clinical Oncology|June 25, 2022
The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world studyJinbin Chen, Peiyao Xiong, Man Nie, et al.
Journal of Hepatocellular Carcinoma|December 9, 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 ImmunotherapyXuqi Sun, Dandan Hu, Zhoutian Yang, et al.
Journal of Hepatocellular Carcinoma|October 26, 2023
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaTeng Long, Zhoutian Yang, Huilan Zeng, et al.
Plant Biotechnology Journal|November 24, 2018
Reconstituting the genome of a young allopolyploid crop, Brassica napus, with its related speciesDandan Hu, Wenshan Zhang, Yikai Zhang, et al.
Pageof 34